Synthesis and processing of molecules bearing thymus leukemia antigen by unknown
SYNTHESIS  AND  PROCESSING  OF  MOLECULES 
BEARING  THYMUS  LEUKEMIA  ANTIGEN* 
BY  ELLEN  ROTHENBERG:~ AND EDWARD A.  BOYSE§ 
From Memorial Sloan-Kettering Cancer Center, New  York 10021 
The  Tla locus, situated ~  1 centimorgan from H-2D, specifies a  number of antigens 
called TL (thymus leukemia) 1 that are expressed only on thymocytes at an early stage 
of their differentiation  and on some leukemias  (1, 2). This locus, which is thought to 
comprise  a  series  of linked  structural  and  regulatory  genes  (3),  has  several  unique 
features.  These cannot  be reviewed here, but  three  points merit  special  attention  in 
the context of the present  report. 
First,  the TL product or products bear a  physico-chemical resemblance  to the  K 
and D  products of H-2 and to at least one of the Qa molecules (4-10) specified by Qa 
genes linked  to  Tla, including association with/8-2-microglobulin.  Thus, TL typifies 
one family of glycoproteins specified by genes in and near the major, histocompatibility 
complex. 
Second,  TL  is  lacking  from  the  pro-thymocyte and  becomes  manifest  when  this 
precursor cell is induced to become a thymocyte; but TL is no longer expressed on the 
fully  differentiated  T  lymphocytes  that  are  derived  from  early  thymocytes.  (It  is 
generally  presumed  that  TL  +  thymocytes represent  a  normal  stage  of T-cell  devel- 
opment, rather than an abortive side branch, but definitive proof is still lacking.) 
Third,  some strains of mice  (TL- strains)  do not express TL on their thymocytes 
and yet do so on many of their leukemias,  the set of TL antigens expressed  on such 
leukemias being different from the TL set expressed by leukemias and thymocytes of 
TL  +  mice.  Thus,  in  these  two  respects  leukemogenesis  is  often  associated  with 
aberrations of TL expression. 
For several reasons TL is an attractive model for studying the synthesis, regulation, 
and posttranscriptional elaboration of glycoprotein species selectively incorporated in 
the plasma membrane in the course of differentiation.  As groundwork for such studies, 
we have investigated  the synthesis and processing of TL molecules, whose expression 
might be expected to depend on appropriate association with/~-2-microglobulin  (11, 
12)  as well as a  prescribed sequence of posttranslational  glycosylation steps which is 
doubtless a  general feature of the synthesis of cell-surface glycoproteins (13-17). High 
resolution  gel electrophoresis was used to resolve different TL species obtained  from 
lactoperoxidase-iodinated  cells, in which the label is confined to molecules accessible 
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at the cell surface, and from metabolically labeled cells, which also yield intracellular 
molecules bearing TL antigen. The various TL products were characterized according 
to  the  kinetics of metabolic labeling and to  their carbohydrate chains.  From these 
data it was possible to identify one intracellular glycoprotein which appears to be the 
presursor  to  cell-surface  TL,  and  a  second  distinct  glycoprotein which  may  be  a 
product of the Qa-1  locus (18). 
Materials and Methods 
Animals and Cells.  All animals were bred and maintained in our colony at Memorial Sloan- 
Kettering Cancer Center. C57BL/6-Tla a  (B6-Tla a)  mice aged 3-6 wk were the source of all 
tissues from normal TL-positive mice. Age matched, B6-Lyt-2.1:3.1  and B6.K2 (19) mice served 
as TL-negative controls, the former for reasons of availability and the latter for reasons given 
in the text. The A strain leukemia ASL1  was  passed at  10-d intervals in A/J mice. A tissue 
culture-adapted line of ASL1 cells, ASL1.1, was obtained from Dr. R. Hyman (Salk Institute). 
Antisera.  The antiserum against TL.1,2,3,5 from  (B6  ×  A-Tlab)Fa  mice immunized with 
ASLI  cells  is the standard TL-typing serum. A single pool was used throughout this work. 
There was no detectable difference between the molecular species precipitated by unabsorbed 
antiserum and species  precipitated  by  antiserum that  had  been absorbed with  AKR  K36 
leukemia cells to remove antiviral activity. Therefore, unabsorbed serum was used routinely. A 
pool of normal mouse serum  (NMS),  from strain  129  mice, was  provided by Dr.  L.  Silver 
(Memorial Sloan-Kettering Cancer Center). Rabbit antiserum against rat/~-2-microglobulin 
was a kind gift of Dr. L. Hood (California Institute of Technology). 
Cell Culture  and Metabolic  Labehng.  Normal thymuses or spleens,  or enlarged spleens from 
mice carrying the ASL1 tumor, were removed aseptically and minced in Dulbecco's phosphate- 
buffered saline (PBS). Clumps were allowed to settle, and the cells released into the supernate 
(>90%  viable) were collected by low-speed  centrifugation, washed  with  PBS,  counted, and 
suspended at a density of 1-5  ×  107/ml  for labeling. The labeling medium (prepared at this 
institute) was RPMI-1640 without methionine, supplemented with 50/~M 2-mercaptoethanol 
and 2% heat-inactivated fetal bovine serum. [3sS]Methionine, in sterile aqueous solution (New 
England Nuclear, Boston, Mass. translational grade), was added at 200-250/LCi/ml. For pulse 
labeling, the cells were initially suspended in the labeling medium without radioactive methi- 
onine and incubated at 37 ° for 10 min, to deplete intracellular methionine before addition of 
the label. The non-radioactive medium used for chase after a pulse label was RPMI-1640 with 
20% heat-inactivated fetal bovine serum and 50 ~M 2-mercaptoethanol. 
To  compare  labeling with  radioactive sugar  and radioactive methionine, the  cells  were 
incubated for  12.5 h in medium with 8% serum, one-third of the normal methionine concen- 
tration, and either [35S]methionine (200 ~Ci/ml), or [5,6-3H]fucose (100/~Ci/ml) (New England 
Nuclear). 
After labeling, cells were washed in RPMI-1640 without additives, and then either washed 
again in PBS before lysis or suspended in chase medium. The chase incubation was terminated 
by washing twice in ice-cold  PBS.  The cells were  lysed in isotonic phospahte-buffered saline, 
pH  7.2, with  1 mM EDTA,  1%  Nonidet P40,  0.5% sodium deoxycholate, and 0.1% sodium 
dodecyl suflate (SDS), at a concentration of 2-10  ×  10  7 cells/ml. For cells harvested from the 
spleen, 1 mM phenylmethyl sutfonyl fluoride (PMSF, Sigma Chemical Co., St. Louis, Mo.), an 
inhibitor of serine proteases,  was added to the lysis buffer. 
Lactoperoxidase-catalyzed  Radioiodination.  Cells suspended at a concentration of ~ 108 per ml in 
PBS were iodinated by incubation with  100 #g of lactoperoxidase (Sigma Chemical Co.)  and 
2-2.5 mCi of Na 125I (Amersham Corp., Arlington Heights, Ill.) at 22-25°C. The reaction was 
initiated by addition of 0.25/~mol of H202,  with a second addition 5-10 min later. After the 
second 5- to 10-rain interval, the reaction was terminated by washing the cells three times with 
50 ml of ice-cold  PBS containing 5 mM KI and 1 mM PMSF. The protease inhibitor, PMSF, 
could  be  omitted  for  thymocytes.  Radioiodinated cells  were  then  lysed  as  described  for 
metabolically labeled cells. 
Immune  Precipitation.  Before  use for  immune precipitations, all lysates were  precleared of 
material that precipitated nonspecifically.  A 10% suspension of fixed, heat-killed Cowan I strain 
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Diego, Calif.) was added to each lysate, at a  concentration of --10 mg of bacterial cells per 
milliliter  oflysate. After 15-60 min on ice, the lysates were clarified by centrifugation at 100,000 
g  for  90  rain.  The  radioactivity incorporated  into  protein  was  measured  by  determining 
trichloroacetic acid (TCA)-precipitable,  ethanol-insoluble radioactivity in samples of the lysates. 
Precleared lysates were stored at -70°C. After each thawing, the lysates were clarified in the 
Eppendorf microcentrifuge (Brinkmann Instruments, Inc., Westbury, N. Y.) before use. 
For immune precipitation, samples of the lysates were incubated at 0°C for 10-20 h with a 
predetermined excess of anti-TL serum, usually 2/zl of a  1:10 dilution of the serum per 100/zl 
of lysate (107 cell eq). An equivalent amount of NMS was used in the controls. The immune 
complexes were collected in a 30- to 120-rain incubation on ice with fixed S. aureus as described 
by Kessler (20).  Precipitates were washed  four times with  PBS with  1% Nonidet  P40,  0.5% 
sodium deoxycholate, and 0.1%  SDS, then once with  10 mM Tris-HC1 pH 7.5, 0.1%  Nonidet 
P40. Bound IgG and antigen were usually released from the immune adsorbent by heating for 
5 min at 80°C in sample buffer containing 2.4% SDS, 10% glycerol, 5% 2-mercaptoethanol, 65 
mM Tris-HCl pH 6.8, and 0.002-0.01% bromophenol blue. 
Slab Gel Electrophoresis.  Samples were fractionated by eleetrophoresis  on SDS-polyacrylamide 
gels, using a modification of the discontinuous buffer system of Laemmli (21).  The separating 
gels were usually  10.5-11.5%  polyacrylamide (acrylamide monomer:  N,N-dimethyl bisacryl- 
amide  30:0.8),  in  0.75  M  Tris-HCl,  pH  8.8,  and  0.2%  SDS.  The  stacking gels were  3.6% 
polyacrylamide, 0.125  M  Tris-HCl  pH  6.8,  and  0.2%  SDS.  Electrophoresis was  at  35  mA 
constant current. 
After electrophoresis, the gels were stained with Coomassie brilliant blue, destained with 
10% acetic acid, and processed for fluorography as described by Bonner and Laskey (22). The 
dried  gels  were  exposed  to  presensitized  x-ray  film  (Kodak  XR-2,  Eastman  Kodak  Co., 
Rochester, N. Y.) at -70°C to obtain an approximately linear intensity response (23). 
Treatment  with  Endo-fl-N-acetylglucosaminidase  H.  Endo-fl-N-acetylglucosaminidase H  (endo 
H) was a  kind gift of Dr. P. W. Robbins (Massachusetts Institute of Technology, Cambridge, 
Mass.). It was dissolved in  10 mM potassium phosphate buffer, pH 8.0, at a concentration of 
100 pg/ml, and stored in aliquots at -70°C. 
Samples were prepared for endo H  digestion by immune precipitation as described above, 
except that the samples were released from the immunoadsorbent by heating in  1% SDS, 0.05 
M Tris-HCl pH 6.8. The bacteria were removed by centrifugation, and aliquots of the supernate 
were diluted with an equal volume of 0.15 M  Na citrate buffer, pH 5.5. The enzyme was then 
added, and the samples were incubated for 1-12 h at 30-31°C. After digestion, 1/10 vol of 20% 
SDS  was  added  to  each  sample,  the  samples  were  heated  to  80°C  for  5  min,  and  the 
macromolecules were recovered by precipitation with 3-5 vol of ice-cold acetone. 
Results 
TL Molecules  within  the  Cell and in  the Plasma Membrane.  TL antiserum, directed to 
the antigens TL. 1,2,3,5, was used to detect molecules with TL specificity in lysates of 
B6-Tla a  (TL  +)  thymocytes and  of ASL1  leukemia cells of the  A  mouse  strain. The 
Tla ~ haplotype of the recombinant  congenic strain B6-Tla a  was derived from  the A 
strain. Thus,  in both cells types the TL antigens, and any other antigens specified by 
genes in the differential segment  of chromosome  17  (Qa:Tla  region)  bounded  by the 
cross-over points, should be the products of the same block of genes. 
Newly synthesized proteins were  labeled biosynthetically by  incubating  the cells 
with  [a~S]methionine for 3-4 h.  Molecules accessible at the cell surface were labeled 
with  a2~I by  catalysis with  lactoperoxidase. After each  of these  procedures,  labeled 
molecules bearing TL were identified by reaction with TL antiserum, collection with 
fixed S.  aureus,  denaturation with SDS, and resolution by polyacrylamide gel electro- 
phoresis (PAGE). 
Fig.  1 shows  several  distinct  TL  species.  In  lysates of iodinated  thymocytes  and 
ASL1  cells, TL  appeared  in  two  forms,  represented  by a  well-defined major  band 
migrating with the mobility of a  polypeptide of 46,000 daltons (46K TL) and a  more 780  SYNTHESIS  AND  PROCESSING  OF  THYMUS  LEUKEMIA  ANTIGEN 
Fro.  1.  Surface and intracellular forms ofTL.1,2,3,5 glycoproteins. (A) Lysates of ASL1  leukemia 
cells and B6-Tla"  thymocytes, labeled either by lactoperoxidase-catalysed radioiodination of intact 
cells  or  by  metabolic incorporation  of [aSS]methionine,  were  incubated with  NMS  or  with TL 
antiserum. The precipitates were collected with S. aureus Cowan I strain, solubilized in sample buffer 
that contained SDS and 2-mercaptoethanol, and analyzed by electrophoresis on  11.5% polyacryl- 
amide gels. Metabolic labeling was for 3.5-4 h. The amount of TCA-precipitable radioactivity in 
each sample before precipitation  is given  in  parentheses.  Lane  1:  [nSS]methionine-labeled ASLI 
lysate, precipitated with NMS (5.1  ×  106 cpm).  Lane 2:  anti-TL precipitate of 12SI-labeled ASLI 
lysate (1  ×  106 cpm).  Lane 3: anti-TL precipitate of [aSS]methionine-labeled ASLI  lysate (7.5  × 
106 cpm). Lanes 4 and 5: anti-TL precipitate, laSI-labeled thymoeyte lysate (2.7  x  10  '~ cpm). Lane 
6:  anti-TL precipitate, [sSS]methionine-labeled thymocyte lysate (4.1  ×  10  ~ cpm).  Lane 7:  NMS 
precipitate, [aSS]methionine-labeled thymocyte lysate (4.1  ×  106 cpm). Samples  1-4 and 5  7 were 
analyzed on separate gels.  Fluorographic exposure was at  -70°C  for  14 d  (lanes  1 4)  or for 9 d 
(lanes 5-7).  In  this and subsequent  figures,  radioactive immunoglobulin  (T and  L  in  figure)  is 
symhesized by B splenocytes contaminating the ASL1  cells;  these molecules bind to the S.  aureus 
immunoadsorbent and copurify with the immune precipitate. The position of~8-2-microglobulin in 
lanes 2 and 3 is indicated by an arrow. Apparent molecular weights of TL species  (×  10  -a daltons) 
are  indicated.  (B)  Lactoperoxidase-radioiodinated thymocytes from  B6-Tla"  (lane 8)  and  B6.K2 
(lane 9) mice were incubated with TL antiserum, and the precipitates were analyzed by electropho- 
resis on  10% polyacrylamide gels. The input radioactivity before precipitation was 3.8  ×  l0  p cpm 
for lane 8 and 1.8  X  l0  b cpm for lane 9. Autoradiography was for 4 d. 
diffuse component  with an apparent  mol wt  (Mr) of 47,000-48,000  dahons  (48K TL). 
Thymocytes  usually  gave  a  more  prominent  and  better-defined  48K  TL  component 
than  did ASL1  cells  (Fig.  1,  lanes 2,  4, and  5). 
Expression of both  46K and  48K TL  is controlled by genes closely linked to the  Tla 
locus,  because  neither component  was detected  in the thymocytes  of congenic recom- 
binant  B6.K2  mice  (Fig.  1, lanes 8  and  9). Although  B6.K2  mice are indubitably  TL- 
negative (genotype  Tla b)  in immune  cytotoxicity assays,  it is not yet  certain that they 
lack  all  or  only  some  of  the  several  Qa  antigens  recognized  by  the  TL  antiserum. 
Therefore  more rigorous identification of the 46K and  48K molecules as TL  must  rest 
on further evidence,  given later in this report. 
Internal  labeling  with  [aSS]methionine yielded  both  46K  and  48K  TL  and  also  a ELLEN  ROTHENBERG  AND  EDWARD A.  BOYSE  781 
Fie.  2.  Pulse-chase analysis of TL from ASL1 cells. ASL1 cells were pulse-labeled for 15 min with 
I;~"Slmethionine, then  incubated in complete  medium  without  label for various periods of chase. 
Samples representing the lysate of 6 x  10  n cells were precipitated with equivalent concentrations of 
normal mouse serum (lanes a, d, g, and j) or TL antiserum  (lanes b, e, h, and k). TCA-precipitable 
radioactivity in each sample before immune precipitation is given in parentheses. Lanes a and b: 0- 
min chase (2,400,000 cpm). Lanes d and e: 20-min chase (2,100,000 epm). Lanes g and h: 60-min 
chase  (1,800,000 epm).  Lanes  j  and  k:  180-min chase  (1,500,000 cpm).  Lanes  c,  f,  i  and  1: 
radioiodinated thymoeyte lysate precipitated with anti-TL serum. Fluorography was at -70°C for 
14d. 
third species with an apparent Mr of 45,000 daltons (45K TL)  (Fig. 1, lanes 3 and 6). 
This  molecule  was  not  accessible  for  iodination  in  intact  cells;  even  prolonged 
autoradiographic exposure revealed no iodinated component with this mobility. Thus, 
unless 45K TL  is a  rare cell-surface molecule which  lacks tyrosine, it is evidently an 
exclusively intracellular form of TL. 
Both  internally  labeled  and  iodinated  immune  precipitates  (visible  on  longer 
exposure)  included  a  labeled  subunit  of  low  molecular  weight  identified  as  fl-2- 
microglobulin by its comigration with the major product of precipitation with rabbit 
antiserum to rat fl-2-microglobulin. 
Precursor-Product Relationships of TL Molecular Species.  The relations of the 45K, 46K, 
and  48K  varieties of TL  to  one  another  were  investigated by pulse-chase  labeling, 
which  permits the study of newly formed proteins which  have undergone  posttrans- 
lational processing for selected intervals of time. Ceils were labeled briefly with [aSs]- 
methionine (pulse) and then exposed during various time intervals to nonradioactive 
(cold) methionine (chase). 
The results of these pulse-chase analyses in ASL1 cells and  thymocytes are shown 
in  Figs.  2  and  3,  respectively. In each  case, cells were  labeled for  15  min  and  then 
chased with cold methionine for up to 3  h.  The metabolically labeled TL  molecules 
were compared in each case with iodinated cell-surface TL. 
In both cell types, the only TL species labeled by a  15-min pulse was 45K, migrating 
distinctly faster than  any iodinated cell-surface species (Fig. 2, lanes b  and c;  Fig. 3, 782  SYNTHESIS  AND  PROCESSING OF THYMUS  LEUKEMIA ANTIGEN 
FIG. 3.  Pulse-chase analysis of TL in B6-Tla a and congenic TL-negative thymocytes. Thymocytes 
from  B6-TIa"fFL +)  or eongenic B6-Lyt-2.1:3.1 (TL-) mice pulse-labeled  and chased  as in Fig. 2. 
Samples  of TL  ÷ represent  2.4  ×  10  '  cell equivalents; samples  of TL- represent  3.1  ×  10  v cell 
equivalents. Lane a: NMS precipitate from TL  ÷ cells, 20-min chase. Lane n: NMS precipitate from 
TL- cells, 60-rain chase. All other samples precipitated with TL antiserum. Lane b, TL- cells, 0- 
min chase; lane c, TL  + cells, 0-min chase. Lane e, TL- ceils, 20-min chase; lane f, TL  + cells, 20-min 
chase. Lane h, TL- cells, 60-min chase; lane i, TL  + cells, 60-rain chase. Lane k, TL- ceils, 180-min 
chase; lane 1, TL  ÷ cells, 180-min chase. Samples ofTL  + cells before precipitation contained 2.3-3.1 
X  106 cpm in protein, depending upon the time of chase, and samples of TL- cells contained 2.9- 
4.4  ×  106 cpm before precipitation. Lanes d, g, j, and m: anti-TL precipitate of radioiodinated 
ASLI cell lysate. Fluorography was at -70°C for 7 d. The position of actin is marked (a). 
lanes c  and d).  The  cell-surface TL  species 46K and 48K were only detectable after 
chase times of 60 rain or more, and substantial accumulation of these molecules was 
only evident  after  a  chase  of 3  h  (Fig.  2,  lane  k;  Fig.  3,  lane  1).  By  this  time  the 
amount  of radioactivity  in  45K  TL  had  clearly  declined.  These  labeling  kinetics 
suggest that  45K TL  may be a  precursor which is converted to the cell-surface forms 
of posttranslational processing over a  period of 1-3 h. 
Conservation of radioactivity among  all the TL  species throughout  the chase  was 
poorer in ASL1  cells than in thymocytes (Fig. 2, lanes b, k; cf. Fig. 3, lanes c,  1). This 
may be due in part  to a  higher overall rate of protein turnover in the leukemia cells, 
or to selective degradation of surface TL  by proteases  contaminating  the cell prepa- 
ration. In the  latter case,  the  rate  of production of 46K and 48K may be underesti- 
mated  (cf. Fig. 2, lane h, and Fig. 3, lane i). 
In ASL1  cells, 48K TL  could  not be  quantitated  because  of the  low  yield and  a 
nonspecific  background  band  in  the  same  position.  In  thymocytes,  however,  the 
distinction of 48K TL  from  background was clear and  its appearance  was  easier to 
follow. No evidence could be found for conversion of 46K TL  to 48K TL. 
The  identification of a  presumptive precursor  (45K TL)  to  cell-surface TL  raises 
the  question whether  thymocytes of  Tla b  genotypes make  45K TL  which  fails to  be 
converted  to  46K/48K  TL.  This is an  important  point  in view of our  ignorance of 
how TL comes to be expressed  on leukemia cells of these TL-negative mouse strains. ELLEN ROTHENBERG AND EDWARD A. BOYSE  783 
Therefore, TL-negative thymocytes were examined for intracellular TL after pulse 
labeling and various periods of chase (Fig. 3 b, e, h, and k). No 45K TL was detectable 
in these lysates at any point. In occasional samples, nonspecific background precipi- 
tation was severe, and a band of actin was conspicuous at 43,000 daltons (Fig. 3 b). 
This  could  be  distinguished  from  authentic  45K  TL,  however,  by  a  slight  but 
definitive difference in mobility. Thus, it was possible to ascertain that TL- thymo- 
cytes  do  not  make  any  methionine-labeled  product  which  is  recognized  by  TL 
antiserum. Evidently TL- thymocytes can do without TL altogether or substitute for 
it a gene product which does not cross-react immunologically. 
High-mannose  Carbohydrate  in  45K  TL.  Molecules precipitable with TL antiserum 
have  been  characterized  as  glycoproteins  (5).  Therefore  some  of the  differences 
between the forms of TL may reside in their carbohydrate portions. 
Carbohydrate can be attached to proteins via an alkali-resistant bond to asparagine, 
or alternatively through an alkali-sensitive linkage to serine, threonine, or hydroxy- 
lysine (24). These later oligosaccharides, which are most common in secretory proteins, 
have structures and compositions very different from those of the asparagine-linked 
sugars, and the time of their addition to newly synthesized polypeptides is not known. 
The major histocompatibility antigens of humans and mice apparently lack this class 
of carbohydrate  (25,  26),  and  no  attempt  was  made  to  look  for  alkali-sensitive 
carbohydrate in TL in this study. 
Glycoproteins may contain two types of asparagine-linked oligosaccharides: first, a 
high-mannose type, of simple composition, containing N-acetylglucosamine, occasion- 
ally  glucose,  and  as  many  as  ten  mannose  residues;  and  second,  a  low-mannose 
complex type, which contains only three or four mannose residues but may include 
fucose, galactose, and  sialic acid  (24,  27).  It  has been proposed that  high-mannose 
oligosaccharides are initially added en bloc to nascent or newly-synthesized glycopro- 
teins  (27-33);  the  complex-type oligosaccharides  are  derived  from  these structures 
subsequently by removal of the glucose and excess mannose residues and addition of 
the other sugars.  Therefore an intracellular precursor of a  cell surface glycoprotein 
might be expected to contain the simple high-mannose type of side chain. 
To test for such a  high-mannose side chain directly, the various TL species were 
assayed for sensitivity to endo H  (34). This enzyme has a well-documented specificity, 
cleaving off the high-mannose type of oligosaccharide side chain close to the aspara- 
gine linkage, but leaving the mannose-poor complex-type oligosaccharides untouched 
(27,  34).  Alteration of the  mobility of a  protein on SDS-PAGE by treatment  with 
endo H  would  be direct  evidence of that  protein's association  with  high-mannose 
oligosaccharide. 
Different concentrations of endo H  were used to digest the TL products of [~S]- 
methionine-labeled ASL 1 cells. Because endo H  tolerates moderate concent.rations of 
detergent, the TL-bearing molecules could first be purified from total cell lysates by 
immune precipitation with fixed S.  aureus  and released by heating in SDS.  Endo H 
digestion products of pulse-labeled TL, TL labeled for 4 h and surface-labeled TL are 
compared in  Fig.  4.  Labeled immunoglobulin, synthesized by splenocytes contami- 
nating the ASL1 population, served as an internal positive control for enzyme activity. 
Pulse-labeled 45K TL, as well as pulse-labeled immunoglobulin, was sensitive to endo 
H  (Fig.  4,  lanes  1-3),  the  45K  band  being  replaced  primarily  by  a  new  species 
migrating faster than actin and with an Mr of ~  40,000 daltons. The reaction was 
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Fro. 4.  Endo H digestion of ASL1 TL. TL antigens were isolated by immune precipitation from 
lysates of ASLI cells labeled for 15 min (lanes 1-3) or for 4 h (lanes 4-8) with [~S]methionine or 
surface-labeled by lactoperoxidase-catalyzed  radioiodination (Lanes 9 and  10). The samples were 
divided into equal  aliquots  and digested with different amounts  of endo  H  at 30°C  for 75 min 
(lanes 1-8) or for 12 h (lanes 9 and 10). Lane 1: no endo H. Lane 2:1/tg/ml endo H., Lane 3:10 
pg/ml endo H. Lane 4: no endo H. Lane 5:0.3/xg/ml endo H. Lane 6:1 pg/ml endo H. Lane 7:3 
~g/ml endo H. Lane 8:10 p.g/ml endo H. Lane 9: no endo H. Lane 10:3 ~g/ml endo H. The dye 
front, including the/~-2-microglobulin band, was run off the gel. 
labeling for 4 h  the labeled molecules migrating as 45K TL were still sensitive to endo 
H  (Fig. 4, lanes 4-8). In contrast, there was no loss or change in the mobility of 46K 
and 48K TL  in these samples or in the iodinated samples. No labeled 40,000-dalton 
product was generated by digestion of surface-iodinated TL  (Fig. 4, lanes 9,  10). 
Two  conclusions  emerge  from  these  data.  First,  the  change  in  electrophoretic 
mobility of45K TL cannot be ascribed to general protease contamination in the endo 
H  preparation. Thus,  the susceptibility of 45K TL  to this enzyme  is a  result of the 
presence of carbohydrate of the  high-mannose  type.  Secondly, any carbohydrate in 
the cell-surface forms, 46K and 48K TL, must have a  different structure. 
The  pattern  of susceptibility  to  endo  H  provides  further  insight  into  possible 
relationships between the TL species. 
Migration of the major digestion product from 45K TL labeled for 4 h was identical 
to that of the 40K product of pulse-labeled 45K TL. Therefore, few if any intermediate 
processing steps, such as proteolytic cleavage or addition of serine- or threonine-linked 
sugars,  are concealed by a  compensating  heterogeneity  in  the  high-mannose  carbo- 
hydrate of 45K TL. More probably, 45K TL is a  unique and uniform species. 
Furthermore, the resistance of 46K and 48K TL to endo H  indicates that probably 
neither  possesses any  high-mannose  chains.  If they possess asparagine-linked carbo- 
hydrate, it must be exclusively of the complex type. The all or none behavior of 45K 
and  46K  TL  may  indicate  that  there  is  only  a  single  carbohydrate  chain  per ELLEN ROTHENBERG AND EDWARD  A.  BOYSE  785 
FIG. 5.  Metabolic sugar labeling of ASLI  TL.  ASLI  cells were labeled  for  12.5 h with  [a~S]- 
methionine or [aH]fucose. Samples were precipitated  with TL antiserum. Lane  1: fucose-labeled 
lysate. Lane 2: methionine-labeled lysate. 
glycoprotein molecule, or alternatively that different carbohydrate chains attached to 
the polypeptide are processed for the most part synchronously. 
Carbohydrate of Cell Surface  TL.  Further evidence for complex-type oligosaccharide 
in cell surface TL was provided by direct metabolic sugar labeling.  As shown in Fig. 
5, both 46K and 48K TL were labeled after a  12.5-h incubation with  [5,6-aH]fucose. 
This sugar is not interconverted with other monosaccharides before it is incorporated 
into glycoproteins (35); therefore both cell-surface TL species are fucosyl glycoproteins. 
Addition of fucose is a  late event in the processing of oligosaccharide chains  (36). Its 
presence  in  46K  and  48K  TL  thus  indicates  that  they  are  extensively  processed 
glycoproteins with complex-type oligosaccbarides  (24). 
In other experiments  (data  not  shown),  46K and  48K TL  displayed  more acidic 
isoelectric  points  than  45K  TL,  suggesting  the  presence  of  sialic  acid  in  their 
carbohydrate chains. 
Tissue Specificity  of TL  Species.  The  prototypic TL  antigens  detected  by immune 
cytotoxicity are restricted  to the thymus, being found in  the periphery only in  mice 
with  TL  +  leukemias.  To  identify  the  45K,  46K,  and  48K  molecules  as  TL  more 
accurately, it was important  therefore to determine whether synthesis of these glyco- 
proteins is similarly restricted  to thymocytes. Spleen cells from B6-Tla a and congenic 
TL-negative mice were labeled  with  [35S]methionine for 30 min and  for 3 h, and  the 
lysates were precipitated  with TL antiserum  as shown in Fig. 6. Two discrete species 786  SYNTHESIS  AND  PROCESSING  OF THYMUS  LEUKEMIA ANTIGEN 
Fie.  6.  An antigen in spleen linked to the Tla locus. Spleen cells from normal B6-Tlaa(FL  +) and 
B6-Lyt 2.1, 3.1  (TL-) mice were labeled with [aSS]methionine  for 30 min or 3 h. The lysates were 
then subjected to immune precipitation with TL antiserum, except for the sample shown in lane l. 
The input radioactivity in each sample  before precipitation is given in parenthesis.  Lane  1: 3-h 
labeled TL  + spleen, control  precipitate with  NMS  (4,000,000 cpm).  Lane 2: 30-rain labeled TL  + 
spleen (530,000 cpm).  Lane 3:  30-min labeled TL- spleen (1,160,000 cpm).  Lane 4: 4-h labeled 
ASL1 lysate (same as in Fig. 4, lane 4; 5,000,000 cpm). Lane 5: 3-h labeled TL  + spleen (4,000,000 
cpm). Lane 6: 3-h labeled TL- spleen (6,000,000 cpm). 
were  found  in  the  immune  precipitates (Fig. 6,  lane 5).  Neither was synthesized by 
splenocytes from congenic TL-negative mice (Fig. 6, lanes 3  and 6), and  neither was 
precipitated by normal  mouse  serum  (Fig. 6,  lane  1).  One  of these species, with  an 
apparent Mr of 44,000-45,000  daltons, was labeled within 30 minutes (Fig. 6, lane 2). 
The second, migrating like a  polypeptide of 47,000  daltons, became radioactive only 
after a  longer labeling period (Fig. 6,  lane 5), and  might  be a  derivative of the first 
product.  Precipitates from  surface-iodinated spleen  cells only displayed the  47,000- 
dalton component  (data not shown). 
Thus,  the  peripheral  lymphoid cells of TL-positive mice synthesize  polypeptides 
that are recognized by a  TL antiserum and are expressed under the control of a  gene 
or  genes  linked  to  Tla.  This  result  is  compatible with  the  fact  that  TL  antiserum 
recognizes Qa allotypes expressed on peripheral lymphocytes. 
Of the  two  splenic molecular~ species, the 45,000-dahon  molecule resembled 45K 
TL in both labeling kinetics and mobility on SDS-PAGE. Although Qa antigens are 
serologically distinct from TL antigens  (18), it is not known whether the polypeptide ELLEN  ROTHENBERG  AND  EDWARD  A.  BOYSE  787 
FJc.  7.  Comparative endo H digestion of antigens recognized by anti-TL serum. Antigens reactive 
with TL antiserum were isolated by immune  precipitation from lysates of ASLI.1  tissue culture 
cells, B6-Tla  a thymus, B6-Tla" spleen, and ASLI cells propagated in vivo. In each case the cells were 
labeled with  [~S]methionine  for 3-4 h, except that the ASLI.I cells were labeled for 0.5 h. The 
samples were divided in half and incubated with or without  3.3-10 p.g/ml ofendo H for 1-3 h at 
31°C. Lane 1: ASL1.1, no endo H. Lane 2: ASL1.1, after endo H. Lane 3: thymus, no endo H. Lane 
4: thymus, after endo H. Lane 5: spleen, no endo H. Lane 6: spleen, after endo H. Lane 7: ASLI 
from spleen, after endo H. Lane 8: ASLI from spleen, no endo H. The figure is a composite from 3 
gels, 1-2, 3-4, and 5-8, run on different occasions. 
backbones  of these  glycoproteins  differ.  Therefore  it  was  important  to  determine 
whether  the  pulse-labeled splenic product  was  identical with  the  45K  intracellular 
form of TL. 
If the two molecules were identical, both should migrate identically after digestion 
with endo H. To test this, anti-TL immune precipitates from ASL 1, from thymocytes, 
and  from splenocytes, were digested with endo  H  and compared as shown  in Fig.  7. 
As before, 45K TL  from  thymocytes and  from ASL1  was characteristically sensitive 
to endo H  (Fig. 7, lanes 2, 4, and  7). The 45,000-dahon  splenocyte molecule was also 
susceptible to  endo  H  (Fig.  7,  lane 6),  but  after digestion there  was  no sign of the 
characteristic 40,000 dalton TL product  (of.  lanes 6  and  7). Instead there appeared a 
new digestion product with an Mr of ~35,000  dahons.  If all asparagine-linked sugar 
in the newly made glycoproteins is sensitive to endo  H  (27),  this experiment  defines 
two differences between 45K TL and the splenocyte glycoprotein. First, the splenocyte 
polypeptide is apparently ~5,000  dahons smaller; second, it must contain more high 
mannose carbohydrate to give the apparent mol wt of 45,000 dahons. If the length of 
each high-mannose chain is the same, the splenocyte molecule must possess additional 
sites of glycosylation. Therefore the 45,000 dalton splenocyte glycoprotein is not 45K 
TL, but most likely another gene product. 
Lysates of ASL 1 cells from the spleens of A/J mice contained small amounts of the 
35,000  dalton  endo  H  digestion  product,  as  well  as  the  40,000  dalton  product 788  SYNTHESIS  AND PROCESSING OF THYMUS LEUKEMIA ANTIGEN 
characteristic of TL (Fig.  7, lane 7; also see Fig. 4). However, a  tissue culture line of 
ASL1 cells made only the 40,000 dalton product (Fig. 7, lane 2). Therefore, the 35,000 
dalton  product  in  lysates of ASL1  cells propagated  in  vivo was probably made by 
contaminating splenocytes, and not by the TL-positive leukemia cells. 
Both  products were prominent  in  the thymocyte sample after endo  H  treatment 
(Fig.  7, lane 4). Clearly the two gene products may be synthesized at similar rates in 
unfractionated thymocytes, although in other experiments the 40,000 dalton product 
predominates  (E.  Rothenberg,  unpublished  observations).  The  45K  pulse-labeled 
band  from  thymocytes  is  therefore  composed  of  at  least  two  glycosylated  early 
molecules. The 47,000-dahon  splenocyte molecular species may also be expected to 
contribute to the heterogeneity of the 46,000-48,000  dalton species recognized by TL 
antiserum which appear in a chase. 
Thus, at least two distinct products were defined, both of them related to genes in 
the  Qa:Tla region.  One,  with  a  40,000  dalton  endo  H-resistant  core,  occurs  in 
thymocytes and ASL1  leukemia cells, but  not  in splenocytes. By tissue distribution, 
genetics,  and  serology,  this  glycoprotein  can  be equated  with  TL.  A  second  gene 
product  has  an  endo  H-resistant  core  of  ~35,000  dahons  and  is  synthesized  by 
splenocytes and by thymocytes. Preliminary data suggest that the two gene products 
are synthesized by different sets of thymocytes. This is of much interest, because TL 
is  thought  to  be  the  hallmark  of  a  subterminal  cell  set,  the  major  thymocyte 
population,  that  yields  terminally  differentiated  TL-:Qa  + cells  represented  in  the 
minor thymocyte population and in the periphery. 
Discussion 
We  have  identified  a  group  of  related  glycoproteins  that  appear  to  represent 
precursor and mature forms of the TL molecules in thymocytes and ASL1  leukemia 
cells. These are hardly major methionine-labeled constituents of the ceils, for to obtain 
a  gel band representing at most 200 cpm, it was necessary to use saturating amounts 
of antibody  to  precipitate  antigen  from a  sample of cell  lysate yielding  ~1  ×  106 
cpm. It was possible to follow the synthesis and processing of these molecules largely 
because  of the  high  titer  and  fine  specificity  of the  antiserum,  which  allow  the 
background of nonspecific precipitation to be minimized. 
According to evidence presented here, the processing scheme for these glycoproteins 
seems  to  follow  the  pattern  established  for  a  number  of other  viral  and  cellular 
glycoproteins (27-33).  The first labeled product with TL antigenicity is probably a 
polypeptide  of 40,000  dahons,  containing  enough  asparagine-linked  high-mannose 
oligosaccharide to make it migrate in SDS gels like a  protein of 45,000 dahons. This 
initial  species, 45K TL,  is  apparently  converted  to  a  slower-migrating complex of 
species, 46K and 48K TL, by a series of steps which must include come processing of 
the carbohydrate chains.  Mannose residues must be removed, to make the oligosac- 
charide resistant to endo H, and fucose must be added, probably along with galactose 
and  sialic  acid.  Whether,  in  addition,  the  polypeptide  is  subjected  to  proteolytic 
cleavage or further glycosylation at other sites is not known. In any case conversion to 
the 46K TL form seems to be a prerequisite for display of the TL glycoprotein on the 
cell surface. 
All these processing steps are potential control points, and so it was important to 
examine  phenotypically  TL-negative tissues,  such  as  spleens  of genotypically TL- 
positive mice, and genotypically TL-negative tissues, ie, thymuses of genetically TL- ELLEN ROTHENBERG AND EDWARD A.  BOYSE  789 
negative  mice.  In  neither  case  was  45K  TL,  the  intracellular  precursor  species, 
detectable. Therefore, in these two cases, a block in the conversion of 45K to surface 
TL is not the cause of the TL-negative phenotype. However, in the interpretation of 
these results, it must be emphasized that every molecule successfully precipitated here 
by the anti-TL serum is glycosylated. There is no evidence as yet that the stripped 
polypeptide backbone of the molecule or an aberrantly glycosylated TL glycoprotein 
can be recognized by TL antiserum.  Therefore it  is possible that  a  defect in initial 
glycosylation of the  nascent  TL polypeptide  could  make  an  otherwise-normal  TL 
gene product inaccessible to our reagents. Further work will be needed to determine 
whether  any of these  post-translational  processing events  is  used  physiologically to 
regulate the expression of TL. 
Finally,  it  was  possible  to  identify  a  non-TL  product  recognized  by  the  TL 
antiserum in thymus and spleen. Using the glycosidase endo H  to dissect the newly- 
synthesized glycoprotein molecules, we were able to show that the antigen recognized 
in  spleen  is probably a  separate gene product  and  not  an  altered  form of the  TL 
glycoprotein. This gene product is specific for the Tla  a haplotype, and may correspond 
to Qa-1  (18). 
Summary 
Thymus-leukemia (TL) antigens are expressed in murine lymphocytes under strict 
developmental regulation. To elucidate the molecular basis of TL expression, we have 
identified  the molecular species that react with TL antiserum.  At least three species 
can be resolved by metabolic radiolabeling of thymocytes and ASL1  leukemia cells, 
lysis, immune precipitation, and sodium dodeeyl sulfate-polyacrylamide. After a brief 
incubation  with  [aSS]methionine,  the  only  radioactive  molecule  recognized  by TL 
antiserum  is  a  homogeneous  species with  an  apparent  Mr of 45,000  dahons.  This 
molecule, 45K TL, includes  high-mannose-type carbohydrate attached  to a  45,000 
dalton  glycosidase-resistant backbone. In this form, 45K, it is never exposed on the 
cell surface. If pulse-labeled cells are further incubated with nonradioactive methio- 
nine  before lysis,  however,  radioactivity  disappears  from  the  45K TL  species  and 
appears in the slower migrating species 46K and 48K TL. Thus, 46K and 48K appear 
to  represent  products  generated  from  the  45K  TL  precursor  by  posttranslational 
modification.  These  TL  forms  are  displayed  on  the  cell  surface;  they  lack  high- 
mannose  carbohydrate  but  evidently  include  acidic  complex-type  carbohydrate. 
Normal thymoeytes from Qa: Tla-negative mice lack not only the surface forms of TL 
but also the intracellular 45K TL form. 
Peripheral  lymphoid  cells  of Qa:Tla-positive  mice  synthesize  none  of these  TL 
species. But the TL antiserum, which contains Qa antibody, recognizes a distinct gene 
product in spleen and thymus of Qa: Tla-positive  mice. In its pulse-labeled form, this 
molecule,  which  may represent  Qa-1,  has  an  apparent  Mr  of 44,000  dahons,  and 
consists of a  glycosidase-resistant polypeptide core of only 35,000  daltons  linked  to 
more high mannose carbohydrate than 45K TL. 
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